When tumours are uncommon, decisions matter more. Expertise and collaboration turn uncertainty into strategy.
Join us at #IUCS26 & discuss with @DanieleRaggi83, Italy, in presence or virtually!
Discover more & register for free 🧷https://t.co/0vxle5Vv1j
#IUCS#TesticularCancer
🧬 #IUCS26 Poll – Post-chemo residual mass in NSGCT
👨⚕️ 30M with met NSGCT
💉 Complet cisplatin based chemotherapy
🧫 Residual mass biopsy shows:
🔬 Teratoma with somatic transformation sarcoma
💭 What is the best next step?
👉 When biology changes, does surgery become the tx?
Few days to the #IUCS26 Call for Abstracts deadline!
🗓️Deadline: July 10
Showcase your research in urological cancers & join the 2026 programme!
🏆 Awards & Travel Grants
🎤 Mini-Oral opportunities
📍 E-posters onsite
🔗Submit: https://t.co/GxtM41KaY1
#IUCS#urology#cancer
🧬 #IUCS26 Poll – Post EV+pembro: What drives your next move?
🎓A challenging real-world scenario:
Prog after EV + pembro…
✔️Multiple therapeutic options…
💭 So what truly guides your decision?
Join the debate with Syed A. Hussain at #IUCS26
🔗 https://t.co/0vxle5Vv1j